quinacrine has been researched along with Porphyria in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ILIN, II | 1 |
| Tanenbaum, L | 1 |
| Tuffanelli, DL | 1 |
1 review available for quinacrine and Porphyria
| Article | Year |
|---|---|
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Chloroquine; DNA; Eye Diseases; Female; Hemat | 1980 |
1 other study available for quinacrine and Porphyria
| Article | Year |
|---|---|
[THE TREATMENT OF PORPHYRIA CUTANEA TARDA].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Bloodletting; Calcium; Chlorides; Desensitizat | 1963 |